Hepatocellular carcinoma: MR staging and therapeutic decisions. - Wikidata - awgldk - TriplyDB

Hepatocellular carcinoma: MR staging and therapeutic decisions.

Hepatocellular carcinoma: MR staging and therapeutic decisions.

http://www.wikidata.org/entity/Q37863539

about

The clinical use of PET with (11)C-acetate.

P2860

Q38058333-7BCE67F8-10C3-46C9-A3D0-8AD4C7B441A5

P2860

Hepatocellular carcinoma: MR staging and therapeutic decisions.

http://www.wikidata.org/entity/Q37863539

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@en

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@nl

type

label

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@en

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@nl

prefLabel

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@en

Hepatocellular carcinoma: MR staging and therapeutic decisions.

@nl

P1433

Q37863539-A523D48F-3D34-4760-88F9-A5D507222034

P1476

Q37863539-9DBDD4E5-1A58-4A7E-81A7-69EED3A9F821

P2093

Q37863539-7E1AD45F-3620-476D-98F2-25C086ACF777

P2860

Q37863539-0CE8E964-FEFA-45B7-BC79-E812D8D34657

Q37863539-11283376-2F2A-478C-B7BC-B4214B77A368

Q37863539-183707C2-FDB8-47DD-B620-3524E3958CD3

Q37863539-2242B675-C31E-4D2F-9921-EBB5F0F6650D

Q37863539-2490ECD5-13BA-4BDA-AFAB-9C7A13FB7A87

Q37863539-24A3AA40-9756-4B2E-88BB-9D7AC9E6FC62

Q37863539-2AD31E91-1BD7-4AED-B1A6-DE03833DE7F9

Q37863539-3250B614-D6B2-4315-9D48-5983A237700B

Q37863539-328627FB-9C44-4C90-BFED-D3E7CFC0B580

Q37863539-3AA44E94-9EEB-49EF-A52F-4E2FA1C0ACAA

P304

Q37863539-9A6ED17B-683A-44AD-939B-4AA7F5CCD0C1

P31

Q37863539-9929E808-E952-458E-8F40-64FE34161C7B

P356

Q37863539-78569A82-4E08-4A7C-8E44-F1E4E76AE1B3

P433

Q37863539-46F074DF-3F62-41E5-AAF5-5E5FFE985197

P478

Q37863539-0A607E65-18BF-498F-9D5F-6034FD230AB9

P50

Q37863539-17626359-29F9-4418-9046-6CBB2C430BE1

P577

Q37863539-882C1D88-7626-43EC-9F12-08253EC05A8D

P698

Q37863539-D9ED4902-F41A-49EC-BF9E-ED1CED3586F2

P356

S00261-011-9735-8

P1433

Abdominal Imaging

P1476

Hepatocellular carcinoma: MR staging and therapeutic decisions

@en

P2093

Irene Bargellini

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

P304

231-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-011-9735-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Irene Bargellini

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21479803

http://www.w3.org/2001/XMLSchema#string